Pharmacogenomics of the p53 tumor suppre
β
Suxing Liu; W. Robert Bishop; Bimal Dasmahapatra; Yaolin Wang
π
Article
π
2004
π
John Wiley and Sons
π
English
β 214 KB
π 1 views
## Abstract Drug resistance remains a key obstacle to successful cancer treatment. The implementation of pharmacogenomics is widely proclaimed as a route to revolutionize the face of cancer therapy. Here we discuss the pharmacogenomics of the p53 tumor suppressor and its role in cancer chemosensiti